Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration

Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration

MYBL2 (MYB proto-oncogene like 2) is an emerging prognostic marker for malignant tumors, and its potential role in osteosarcoma and its relationship with immune infiltration in pan-cancer is yet to be elucidated. We constructed a transcription factor activity profile of osteosarcoma using the single...

Full description

Bibliographic Details
Main Authors: Xinzhu Qiu, Hongbo He, Hao Zeng, Xiaopeng Tong, Can Zhang, Yupeng Liu, Zhan Liao, Qing Liu
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2024-05-01
Series:Genes and Diseases
Subjects:
Biomarker
Immune checkpoint
MYBL2
Osteosarcoma
Pan-cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2352304223002611

Similar Items

Similar Items